|
Stock Information
Innovive Pharmaceutical’s common stock is listed on the Over-the-Counter Bulletin Board (www.otcbb.com) under the symbol “IVPH.OB.”
If you would like additional information on Innovive, please contact Steven Kelly, President & CEO.
Phone: 212-716-1810
Email: skelly@innovivepharma.com
SEC Filings
Innovive Pharmaceuticals is a publicly reporting company. All of our SEC filings may be accessed below.
For Section 16 filings, Click here
For all other SEC filings, Click here
Transfer Agent
Wells Fargo Shareowner Services
161 North Concord Exchange
South St. Paul, MN 55075-1139
Phone: 1-877-536-3552
Corporate Governance
Innovive Pharmaceuticals is committed to ethical conduct throughout our company. Employees, officers and directors are governed by our Code of Ethics. Our Chief Executive Officer and senior financial officers also must comply with a separate code of ethics to ensure proper financial reporting.
The following are our corporate governance documents in PDF format:
Codes of Ethics:
Code of Business Conduct and Ethics 
Code of Ethics for CEO and Senior Financial Officers
Committee Charters:
Audit Committee Charter
Compensation Committee Charter
|
